CDT Equity Inc

Regan Andrew’s insider buys at CDT Equity reveal a CEO’s confidence, but also heightened governance risks. Understand how his share purchases, capital plans, and AI‑driven health tech could drive shareholder value amid value‑based care trends.

Insider Taylor Mark Andrew’s massive 51 million share purchase signals confidence in CDT Equity’s future, hinting at a possible turnaround tied to upcoming clinical milestones.

Explore how insider buys at CDT Equity Inc. reveal confidence amid a 99% YTD decline—insight on future Nasdaq listing, strategic partnership and drug‑development impact.